The outlook for Vedanta (₹495.60) turned positive after the recent rally. Immediate resistance is at ₹508 and a conclusive close above this will trigger a fresh rally.
Nearest support levels are ₹479 and ₹455. Only a close below the latter will alter the short-term positive view.
F&O pointers: Vedanta Oct futures and Nov futures closed at ₹496.60 and ₹499.95 respectively against the spot price of ₹495.60. Futures witnessed a healthy rollover of about 70 per cent.
Option positioning (November) indicates positive bias as puts witnessed strong addition of open interests. Calls indicate that ₹520 is a potential resistance while puts signal ₹470 is a support.
Strategy: Buy Vedanta 505-November call (₹16.10). As the market lot is 1,150 shares, this strategy would cost ₹18,515. This would be the maximum loss and that will happen if the stock fails to cross ₹505. Hold the position for at least two weeks.
Place initial stop-loss at ₹13. Shift this to ₹16 if Vedanta opens on a positive note. Traders can aim for a target of ₹19-20. If the stock opens sharply higher on Monday, traders can ignore this strategy.
Follow up: Contrary to our expectations, the stock of Auro Pharma slipped and would have triggered the stop-loss. Those who are still holding can exit.
Note: The recommendations are based on technical analysis and F&O positions. There is a risk of loss in trading.
Published on October 25, 2025
